Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: WeirdPro Randy who wrote (838)	10/24/1997 11:21:00 PM
From: Cacaito	Respond to of 1359

Technically, IPIC is now undergoing accumulation, a change in the last four trading sessions, as per BOP from worden brothers tc 2000, caution this is only few sections and need to be comfirmed with a longer time outlook (eg weeks to months), it is not a sign that the price will not keep falling, and it will actually be more predictive if the price do fall more and still accumulation is ongoing. It will be an interesting buy at that time, interesting even if it holds the price. Recently, there was some news in the leptin front small article about apoptosis of fat cells due to leptin use in rats (not from AMGN, neither IPIC). I think there is research from Interneuron together with AMGN in the leptin field , another diet drug!, this one is really safe and promising (from my memory no reference available). Real $billion drug if it comes to reality.